Vanguard Group Inc - Jun 30, 2025 SCHEDULE 13G/A Report for Travere Therapeutics Inc Common Stock (TVTX)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Travere Therapeutics Inc Common Stock
Symbol: TVTX
Shares outstanding: 88.9M shares
Disclosed Ownership: 5.99M shares
Ownership: 6.74%
Form type: SCHEDULE 13G/A
Date filed: 7/29/2025, 02:41 PM
Date of event: Jun 30, 2025
Previous filing: Apr 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	6.74%	5.99M	0	107K	Ashley Grim	Head of Global Fund Administration